Amazing discussion this morning on imaging in the BCR setting of #prostatecancer
#APCCCDiagnostics25
#PSMAPET by Irene Burger
PET PSMA refining patients classification mCSPC #prostatecancer
But what to do with it? Need for clinical trials. #APCCCDiagnostics25 @OncoAlert
LIVE DAY TWO #APCCCDiagnostics25 in Lugano🇨🇭
Dr. Matthew Cooperberg @dr_coops 🇺🇸 discussing
How do genomic classifiers contribute in the
BCR situation?
In 2025, the most definitive role for biomarkers in post-operative BCR is using Decipher to guide the intensification of SRT w/ ADT
LIVE DAY TWO #APCCCDiagnostics25 in Lugano🇨🇭
Dr. Matthew Cooperberg @dr_coops 🇺🇸 discussing How do genomic classifiers contribute in the BCR situation?
In 2025, the most definitive role for biomarkers in post-operative BCR is using Decipher to guide the intensification of SRT w/ADT
LIVE DAY ONE #APCCCDiagnostics25 in Lugano🇨🇭
Dr. Jonas Hugosson🇸🇪 discussing
How do you (best evidenced) screen for prostate cancer?
MRI detects the vast majority of high-grade prostate cancers, but it also identifies 50% of ISUP Grade 1 cancers, especially larger ones
JOIN US at #APCCCDiagnostics25 🇨🇭in Lugano
A HYBRID Meeting (In Person & Live) Switzerland
February 27-28, 2025 REGISTER: apccc.org/apccc-diagno...
ONLINE REGISTRATION FOR LMIC's FREE
@silkegillessen.bsky.social @aureliusomlin.bsky.social @barbaramelao.bsky.social @drnataliagandur.bsky.social
Dear Colleagues
A warm invitation to JOIN US at #APCCCDiagnostics25
A HYBRID Meeting (In Person & Live) in Lugano Switzerland February 27-28, 2025
REGISTER: https://buff.ly/4eSVBsa
Enjoy Early Bird Registration, NOW OPEN
ONLINE REGISTRATION FOR LMIC's FREE‼️
OncoAlert 🚨Will be Livewith Coverage